Hans Klingemann

Hans Klingemann

Teknisk/Vetenskaplig/F&U Direktör på IMMUNITYBIO, INC.
76 år
Health Technology
Consumer Services
Health Services

Profil

Hans Georg Klingemann was the founder of NantKwest, Inc. (founded in 2002) where he held the title of Director, Chief Medical & Scientific Officer from 2012 to 2015.
He is currently the Chief Science Officer–Cellular at ImmunityBio, Inc. Dr. Klingemann's former positions include being an Independent Non-Executive Director at Osiris Therapeutics, Inc. from 2012 to 2016, Director-Bone Marrow Transplant at Rush University Medical Center, Director at Bone Marrow & Cancer Foundation, Inc., and Director-Stem Cell Transplant at Tufts Medical Center, Inc.Dr. Klingemann obtained a doctorate degree from Philipps University of Marburg and the University of Würzburg Medical School.

Aktiva positioner av Hans Klingemann

FöretagPositionStart
IMMUNITYBIO, INC. Teknisk/Vetenskaplig/F&U Direktör -

Tidigare kända positioner av Hans Klingemann

FöretagPositionSlut
OSIRIS THERAPEUTICS, INC. Direktör/Styrelseledamot 2016-06-11
Företagsledare/Principal -
Företagsledare/Principal -
Direktör/Styrelseledamot -
IMMUNITYBIO, INC. Grundare -
Se detaljerna i Hans Klingemanns erfarenhet

Hans Klingemanns utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

37

Första gradens relationer

8

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag8

Health Technology

Health Technology

Consumer Services

Health Services

Commercial Services

Health Services

Consumer Services

Health Technology

  1. Börsen
  2. Insiders
  3. Hans Klingemann